NASDAQ:CRTX - Nasdaq - US22053A1079 - Common Stock - Currency: USD
TTM (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 88.87M | 90.32M | 78.89M | 39.17M | 12.12M | |||
Research and Development | 56.73M | 60.80M | 61.31M | 30.21M | 10.09M | |||
Selling, General, and Administrative Expenses | 32.14M | 29.52M | 17.59M | 8.95M | 2.03M | |||
Operating Income | -88.87M | -90.32M | -78.89M | -39.17M | -12.12M | |||
Interest Income/Expense | 465.00K | 620.00K | 2.04M | 2.19M | -360.00K | |||
Other Income/Expense | -98.00K | -247.00K | N/A | N/A | N/A | |||
Income Before Taxes | -88.50M | -89.94M | -76.85M | -36.98M | -12.48M | |||
Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
Net Income | -88.50M | -89.94M | -76.85M | -36.98M | -12.48M | |||
EBITDA | -88.58M | -89.97M | -78.56M | -38.98M | -12.07M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -2.96 | -3.03 | -2.63 | -1.94 | -0.48 | |||
Non GAAP EPS | -2.97 | -3.03 | -2.63 | -2.90 | N/A | |||
Statistics |
All data in USD